Bacteremia with Streptococcus pneumoniae: Sepsis and other risk factors for 30-day mortality-a hospital-based cohort study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 10, 2012, Pages 2719-2725

  Christensen, J S ^a   Jensen, T G ^a   Kolmos, H J ^a   Pedersen, C ^a   Lassen, A ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GROUPS BY AGE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PATIENT IDENTIFICATION; PNEUMOCOCCAL MENINGITIS; POPULATION RESEARCH; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SEX DIFFERENCE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; CROSS INFECTION; DENMARK; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; YOUNG ADULT;

EID: 84869142359     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1619-5     Document Type: Article

References (27)

1. Konradsen HB, Kaltoft MS (2002) Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol 9:358-365
2. Nielsen SV, Henrichsen J (1996) Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol Infect 117:411-416
3. Kyaw MH, Clarke S, Jones IG, Campbell H (2002) Incidence of invasive pneumococcal disease in Scotland, 1988-99. Epidemiol Infect 128:139-147
4. Dahl MS, Trollfors B, Claesson BA, Brandberg LL, Rosengren A (2001) Invasive pneumococcal infections in Southwestern Sweden: a second follow-up period of 15 years. Scand J Infect Dis 33:667-672
5. Kalin M, Örtqvist Å, Almela M, Aufwerber E, Dwyer R, Henriques B, Jorup C, Julander I,Marrie TJ,MufsonMA, Riquelme R, Thalme A, Torres A, Woodhead MA (2000) Prospective study of prognostic factors in community-Acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 182:840-847
6. Afessa B, Greaves WL, Frederick WR (1995) Pneumococcal bacteremia in adults: a 14-Year experience in an inner-city university hospital. Clin Infect Dis 21:345-351
7. Mufson MA, Stanek RJ (1999) Bacteremic pneumococcal pneumonia in one American City: a 20-Year longitudinal study, 1978-1997. Am J Med 107(1A):34S-43S
8. Örtqvist Å, Kalin M, Julander I, Mufson MA (1993) Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations-Huntington, WVa, and Stockholm, Sweden. Chest 103:710-716
9. Watanakunakorn C, Greifenstein A, Stroh K, Jarjoura DG, Blend D, Cugino A, Ognibene AJ (1993) Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. Chest 103:1152-1156
10. Austrian R, Gold J (1964) Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 60:759-776
11. Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, Lambertsen L, Krogfelt KA, Konradsen HB, Benfield TL (2009) Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 6: e1000081
12. Alanee SRJ, McGee L, Jackson D, Chiou CC, Feldman C, Morris AJ, Örtqvist A, Rello J, Luna CM, Baddour LM, Ip M, Yu VL, Klugman KP; International Pneumococcal Study Group (2007) Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 45:46-51
13. Plouffe JF, Breiman RF, Facklam RR (1996) Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. JAMA 275:194-198
14. Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MB, Andremont A, Klugman KP; International Pneumococcal Study Group (2003) An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 37:230-237
15. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655
16. Russell JA (2006) Management of sepsis. N Engl J Med 355:1699-1713
17. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 27:117-123
18. Shapiro N, Howell MD, Bates DW, Angus DC, Ngo L, Talmor D (2006) The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 48:583-590
19. Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287:2398-2399
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
21. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-Associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309-392
22. Bouza E, Pintado V, Rivera S, Blázquez R, Muñoz P, Cercenado E, Loza E, Rodríguez-Créixems M, Moreno S; Spanish Pneumococcal Infection Study Network (G03/103) (2005) Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin Microbiol Infect 11:919-924
23. Søgaard M, Nørgaard M, Dethlefsen C, Schønheyder HC (2011) Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis 52:61-69
24. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310
25. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Régnier B (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 274:968-974
26. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589-1596
27. Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW (2003) Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 31:670-675